Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Peptide containing doai
Reexamination Certificate
2007-12-20
2010-02-02
Landsman, Robert (Department: 1646)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Peptide containing doai
C530S350000, C530S351000
Reexamination Certificate
active
07655628
ABSTRACT:
The invention relates to the use of SARP-1 for the preparation of a medicament for the treatment and/or prevention of scleroderma, in particular of systemic sclerosis.
REFERENCES:
patent: 5266575 (1993-11-01), Gerster et al.
patent: 5747639 (1998-05-01), Seely
patent: 5858715 (1999-01-01), Surya et al.
patent: 6800735 (2004-10-01), Whitty et al.
patent: 7026445 (2006-04-01), LaVallie et al.
patent: 7045596 (2006-05-01), Umansky et al.
patent: 0328255 (1989-08-01), None
patent: WO 9801555 (1998-01-01), None
patent: WO 9813493 (1998-04-01), None
patent: WO 9835043 (1998-08-01), None
Abraham et al., “Expression and Function of Surface Antigens on Scleroderma Fibroblasts”Arthritis and Rheumatism, 34 (9): 1164-1172.
Abraham et al., “Expression and Function of Surface Antigens on Scleroderma Fibroblasts”;Arthritis and Rheumatism, 34 (9): 1164-1172, Sep. 1991.
Adler et al., “Allelic Variation at thefrizzledLocus ofDrosopphilia” Molecular Biology Institute and Cancer Center, 8:99-119 (1987); Charlottesville, University of Virginia.
Altschul et al., “Basic Local Alignment Search Tool”;J. Mol. Biol.(1990) 215:403-410; Academic Press Limited.
Altschul et al., Stephen F., “Gapped Blast and Psi-Blast: a new generation of protein database search programs”Nucleic Acids Research(1997) 25 (17): 3389-3402.
Bafico et al., “Interaction of Frizzled Related Protein (FRP) with Wnt Ligands and the Frizzled Receptor Suggests Alternative Mechanisms for FRP Inhibition of Wnt Signaling,”The Journal of Biological Chemistry, 274(23): 16180-16187 (Jun. 4, 1999); The American Society for Biochemistry and Molecular Biology, Inc.
Bányai et al., “The NTR module: Domains of netrins, secreted frizzled related proteins, and type I procollagen C-proteinase enhancer protein are homologous with tissue inhibitors of metalloproteases,”Protein Science(1990), 8:1636-1642; Cambridge University Press, USA.
Cavalli et al., “The Stress-Induced MAP Kinase p38 Regulates Endocytic Trafficking via the GDI:Rab5 Complex,”Molecular Cell, 7: 421-432 (Feb. 2000); Cell Press.
Chang et al., “Cloning and characterization of a secreted frizzled-related protein that is expressed by the retinal pigment epithelium,”Human Molecular Genetics(1999) 8(4): 575-583; Oxford University Press.
Devereux et al., “A comprehensive set of sequence analysis programs for the VAX,”Nucleic Acids Research, 12(1) (1984); Laboratory of Genetics, University of Wisconsin, Madison, WI.
Dimmeler et al., “Oxidized Low-Density Lipoprotein Induces Apoptosis of Human Endothelial Cells by Activation of CPP32-Like Proteases: A Mechanistic Clue to the ‘Reponse to Injury’ Hypothesis” (Feb. 20, 1997),Molecular Cardiology, Department of Internal Medicinel IV, Univ. of Frankfurt; American Heart Association, Inc.
Finch et al., “Purification and molecular cloning of a secreted, Frizzled-related antagonist of Wnt action,”Proc. Natl. Acad. Sci. USA, 94: 6770-6775 (Jun. 1997).
Golub et al., “Molecular Classification of Cancer: Class Discovery and Class Prediction by Gene Expression Monitoring,”Science, 286: 531-537 (Oct. 15, 1999).
Grantham, “Amino Acid Formula to Help Explain Protein Evolution”;Science16: 862-864 (Sep. 6, 1974).
Hattori et al., “Bleomycin-induced pulmonary fibrosis in fibrinogen-null mice”;The Journal of Clinical Investigation,106 (11): 1341-1350 (Dec. 2000).
Krein et al., “Growth factor regulation and manipulation in wound repair: to scar or not to scar, that is the question,”Expert Opinion, Monthly Focus: Pulmonary-Allergy, Dermatological, Gastrointestinal & Arthritis, pp. 1065-1079; Ashley Publications Ltd., 2001.
Leighton, “Drug Treatment of Scleroderma”;Therapy in Practice, Drugs(2001) 61 (3): 419-427; Adis International Limited.
Leimeister et al., “Developmental expression patterns of mouse sFRP genes encoding members of the secreted frizzled related protein family,”Mechanisms of Development(1998) 75: 29-42; Elsevier Science Ireland Ltd.
Leroy et al., “Increased Collagen Synthesis by Scleroderma Skin Fibroblasts In Vitro,”The Journal of Clinical Investigation54: 880-889 (Oct. 1974).
Lin et al., “The cysteine-rich frizzled domain of Frzb-1 is required and sufficient for modulation of Wnt signaling,”Proc. Natl. Acad. Sci. USA 94: 11196-11200 (Oct. 1997); The National Academy of Sciences.
Martini et al., “Marked and sustained improvement two years after autologous stem cell transplantation in a girl with systemic sclerosis”;Arthritis&Rheumatism, vol. 42, No. 4, Apr. 1999, pp. 807-811; American College of Rheumatology.
McCormick et al., “Anti-TGF-β Treatment Prevents Skin and Lung Fibrosis in Murine Sclerodermatous Graft-Versus-Host Disease: A Model for Human Scleroderma,”The American Association of Immunologists, pp. 5693-5699 (1999).
Melkonyan et al., “SARPs: A family of secreted apoptosis-related proteins,”Proc. Natl. Acad. Sci, USA, 94: 13636-13641 (Dec. 1997); Cell Biology.
Miller et al., “Mechanism and function of signal transduction by the Wnt/β-catenin and Wnt/Ca2+ pathways”Oncogene(1999), 18: 7860-7872; Stockton Press, 1999.
Mir et al., “High-efficiency gene transfer into skeletal muscle mediate by electric pulses,”Proc. Natl. Acad. Sci. USA, 96: 4362-4267 (Apr. 1999).
Pearson, “Rapid and Sensitive Sequence Comparison with FASTP and FASTA”Methods in Enzymology183: 63-98; Acedemic Press, Inc. 1990.
Pearson, “Improved tools for biological sequence comparison”.Proc. Natl. Acad. Sci. USA85:2444-2448.
Schumann et al., “Altered Expression of Secreted Apoptosis Related Proteins (SARPs) in Failing Human Myocardium Suggests Autocrine Modulation of Wnt/Frizzled Signaling by Cardiac Overload,”Circulation110(18): I-759 (Nov. 2, 1999).
Shevchenko et al., “Mass Spectormetric Sequencing of Proteins from Silver-Stained Polycrylamide Gels,”Anal. Chem.(Mar. 1, 1996) 68: 850-858; American Chemical Society.Rattner, Amir, “A family of secreted proteins contains homology to the cysteine-rich ligand-binding domain of frizzled receptors”; Proc. Natl. Acad. Sci., USA, vol. 94, pp. 2859-.
Shi-Wen et al., “Scleroderma lung fibroblasts exhibit elevated and dysreglated type 1 collagen biosynthesis,”Arthritis&Rheumatism40 (7): 1237-1244 (Jul. 7, 1997); American College of Rheumatology.
Shi-Wen et al., “Fibroblast Matrix Gene Expression and Connective Tissue Remodeling: Role of Endothelin-1,”The Journal of Investigative Dermatology(Nov. 22, 2000) 417-425.
Silman, “Mortality from scleroderma in England and Wales 1968-1985,”Annals of the Rheumatic Diseases(1991) 50: 95-96.
Smalley et al., “Wnt signaling in mammalian development and cancer,”Cancer and Metastasis Reviews18: 215-230 (1999); Kluwer Academic Publishers, Netherlands.
Smith et al., “Identification of Common Molecular Subsequences,”J. Mol. Biol.(1981) 147: 195-197.
Strehlow et al., “Biology of the scleroderma fibroblast,”Current Opinion in Rheumatology(1998) 10: 572-578; Lippincott Williams & Wilkins.
Sule et al., “Update on Management of Scleroderma,”Bulletin on the Rheumatic Diseases, Arthritis Foundation 49 (10): 1-4 (Feb. 20, 2000).
Von Heijene, “A new method for predicting signal sequence cleavage sites,”Nucleic Acids Research(May 5, 1986) 14 (11): 4683-4690.
Wigley et al., “Novel therapy in the treatment of scleroderma”Expert Opinion on Investigational Drugs(2001) 10(1): 31-48; Ashley Publications Ltd.
Wilm et al., “Femtomole sequencing of proteins from polyacrylamide gels by nano-electrospray mass spectrometry,”Letters to Nature(Feb. 1, 1996) 379:466-469.
Yamamoto et al., “Anti-sclerotic Effect of Transforming G
Colinge Jacques
Plater-Zyberk Christine
Power Christine
Browdy and Neimark PLLC
Chandra Gyan
Landsman Robert
Merck Serono SA
LandOfFree
Method for treating liver cirrhosis or interstitial... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Method for treating liver cirrhosis or interstitial..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Method for treating liver cirrhosis or interstitial... will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-4169378